4//SEC Filing
Townsend Richard Nolan 4
Accession 0001995218-25-000003
CIK 0001907108other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:30 PM ET
Size
5.1 KB
Accession
0001995218-25-000003
Insider Transaction Report
Form 4
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-09-12$2.64/sh+2,193$5,798→ 222,251 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]Includes 131,092 Restricted Stock Units.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0001995218
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 5:30 PM ET
- Size
- 5.1 KB